‘At this stage, I’m not ready to get vaccinated’: Some Russian doctors refuse to take Sputnik V shot, citing efficacy concerns

Credit: EPA/Shutterstock
Credit: EPA/Shutterstock

Moscow opened the doors of Russia’s first 70 vaccination centers [December 2], offering healthcare workers and other crucial groups a shot of Russian-developed vaccine Sputnik V.

Since then, only 15,000 people have been vaccinated, according to Moscow Mayor Sergei Sobyanin. It means that on average, each clinic inoculated about 15 people a day.

Empty waiting halls in Moscow clinics and wasted shots could be the symptoms of a larger issue Russia will have to face as the vaccination program expands nationwide: widespread mistrust in its vaccine.

ADVERTISEMENT

Russia approved its first Covid-19 vaccine, Sputnik V, in August after testing it on several dozen people in a study with great fanfare from state TV.

The news of Sputnik V’s approval ahead of large-scale Phase 3 trials necessary to test the vaccine’s safety and efficacy drew considerable criticism from scientific and medical circles who worried that Russia was short-cutting an established process for political and PR gain.

Related article:  Combined immunotherapy strategy could revolutionize kidney cancer treatment
Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

“At this stage, I’m not ready to get vaccinated, as the Russian vaccine is not transparent, and its effectiveness hasn’t been proven,” said Viktoria Alexandrova, a general practitioner in Saint Petersburg. “And all of that because of this absurd political race on who’s going to get the vaccine faster.”

“So maybe in two years,” Alexandrova added.

ADVERTISEMENT
ADVERTISEMENT

Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend